9-89325597-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_024077.5(SECISBP2):c.353G>A(p.Cys118Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_024077.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SECISBP2 | NM_024077.5 | c.353G>A | p.Cys118Tyr | missense_variant | 3/17 | ENST00000375807.8 | NP_076982.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SECISBP2 | ENST00000375807.8 | c.353G>A | p.Cys118Tyr | missense_variant | 3/17 | 1 | NM_024077.5 | ENSP00000364965.3 | ||
SECISBP2 | ENST00000339901.8 | c.134G>A | p.Cys45Tyr | missense_variant | 3/17 | 1 | ENSP00000364959.3 | |||
SECISBP2 | ENST00000470305.1 | n.3398G>A | non_coding_transcript_exon_variant | 1/3 | 1 | |||||
SECISBP2 | ENST00000534113.6 | c.149G>A | p.Cys50Tyr | missense_variant | 3/17 | 2 | ENSP00000436650.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 04, 2024 | The c.353G>A (p.C118Y) alteration is located in exon 3 (coding exon 3) of the SECISBP2 gene. This alteration results from a G to A substitution at nucleotide position 353, causing the cysteine (C) at amino acid position 118 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.